1-2 of 2
Elizabeth A. Sugar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR-004: Systemic and intratumoral immune profiling in metastatic pancreatic cancer patients who received front-line FOLFIRINOX and were treated with combination immunotherapy with CTLA-4 blockade in the maintenance setting

Annie A. Wu, Katherine M. Bever, Won Jin Ho, Elana J. Fertig, Nan Niu, Lei Zheng, Rose M. Parkinson, Jennifer N. Durham, Beth Onners, Anna K. Ferguson, Cara Wilt, Andrew H. Ko, Andrea Wang-Gillam, Daniel A. Laheru, Robert A. Anders, Elizabeth D. Thompson, Elizabeth A. Sugar, Elizabeth M. Jaffee, Dung T. Le
Journal: Cancer Research
Cancer Res (2020) 80 (22_Supplement): PR-004.
https://doi.org/10.1158/1538-7445.PANCA20-PR-004
Published: 13 November 2020
View article titled, Abstract PR-004: Systemic and intratumoral immune profiling in metastatic pancreatic cancer patients who received front-line FOLFIRINOX and were treated with combination immunotherapy with CTLA-4 blockade in the maintenance setting
Journal Articles

Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer

Christine L. Hann, Vincent C. Daniel, Elizabeth A. Sugar, Irina Dobromilskaya, Sara C. Murphy, Leslie Cope, Xue Lin, Jared S. Hierman, Daniel L. Wilburn, D. Neil Watkins, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2008) 68 (7): 2321–2328.
https://doi.org/10.1158/0008-5472.CAN-07-5031
Published: 01 April 2008
View article titled, Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer
Open the PDF for Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer in another window
Includes: Supplementary data